[Physiopathology of cytostatic therapy in mesenchymal diseases].
D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D002247:Carbon Isotopes; D003094:Collagen / Q000378:metabolism; D003238:Connective Tissue / Q000187:drug effects; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use*; D006026:Glycoside Hydrolases / Q000097:blood; D009946:Organothiophosphorus Compounds / Q000494:pharmacology / Q000627:therapeutic use; D010756:Phosphoric Acids / Q000627:therapeutic use*; D011392:Proline / Q000378:metabolism; D051381:Rats; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000503:physiopathology
D000081:Acetamides; D002247:Carbon Isotopes; D009946:Organothiophosphorus Compounds; D010756:Phosphoric Acids; D003520:Cyclophosphamide; D003094:Collagen; D011392:Proline; D006026:Glycoside Hydrolases
Zur Pathophysiologie der zytostatischen Therapie von Mesenchymerkrankungen.